baber/WOPTO huggingface dataset:
Patent CA-2549275-A1 (CA)
Title: Neoplasia-specific splice variants and methods
Inventor: MORRE D JAMES
IPC: C12N1/21
Filed: 2006-06-27
Abstract: All neoplastic cells express a unique cell-surface ubiquinone (NADH) oxidase with protein disulfide-thiol isomerase with characteristic sensitivity to inhibition by capsaicin, sulfonylureas, adriamycin and certain other compounds. This neoplasia-specific protein is the translational expression production of a particular splice pattern: exon 4 is not translated to become part of the neoplasia-specific protein displayed on the surfaces of the cancer cells. Oligonucleotides which span the splice junctions of the cancer-specific mRNA can be used in RT-PCR assays, for example, having nucleotide sequences as given in SEQ ID NO:4 and in SEQ ID NO:5, which, when positive, are useful in the detection of neoplastic cells in the sample from which the mRNA  was derived. Alternatively, transcriptase or real time polymerase chain reaction assays can produce amplification products of cancer-specific sizes. In addition, antisense oligonucleotides which inhibit the expression of the neoplasia-specific transcript are disclosed; these restore the normal phenotype of neoplastic cells into which they are introduced.
Patent CA-2554333-A1 (CA)
Title: Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Inventor: WANG ZHAOYIN
IPC: A61P29/00
Filed: 2005-01-25
Abstract: The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases. Formula (I). The invention also encompasses certain pharmaceutical compositions and methods for treating cyclooxygenease-2 mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions while also reducing the risk of thrombotic cardiovascular events.
Patent CA-2554499-A1 (CA)
Title: Linear incendiary strand and method for prescribed fire ignition
Inventor: REISTROFFER JEFFREY P
IPC: C06C9/00
Filed: 2005-02-01
Abstract: An elongate, flexible, incendiary device for producing a nearly instantaneous source of flaming combustion along a linear pathway of indeterminate length.  The incendiary device is provided in the form of a solid, continuous strand, such as, for example, a ribbon, tape, cord, filament, rope or tube. The device is comprised of means for rapid ignition along the longitudinal axis of the strand in co-linear arrangement with a solid or semi-solid combustible fuel composition. Upon ignition, the device produces flames from its exterior surface for a duration of time suitable for igniting nearby combustible matter. The incendiary device provides a nearly instantaneous line of fire for igniting prescribed fires, controlled burns, and backfires. A method for igniting vegetative matter over an area of land using one or more indeterminate lengths of a rapidly igniting linear incendiary strand.
Patent CA-2554781-A1 (CA)
Title: Method and system for image processing for profiling with uncoded structured light
Inventor: RODRIGUES MARCOS A
IPC: G06V10/145
Filed: 2005-02-03
Abstract: A 3D scanning apparatus configured to image a physical entity comprises a radiation projector for projecting a plurality of radiation stripes onto the physical entity, a detector for detecting striped radiation received from the physical entity; and a data storage device for storing the received radiation as a pixellated bitmap image, the apparatus characterised in that the physical entity, the radiation projector and the detector are geometrically arranged to constrain the number of times that each received stripe is permitted to occur in a given pixel row of the bitmap, the geometrica) constraint determining a stored occlusion classification comprising a plurality of types of occlusions and the apparatus additionally comprising an occlusion type processing means configured to utilise the classification for detecting the various types of occlusions in said received image data.
Patent CA-2554860-A1 (CA)
Title: Pharmaceutical composition and method for the transdermal delivery of magnesium
Inventor: BRIERRE BARBARA T
IPC: A61K31/4415
Filed: 2005-02-24
Abstract: The present invention relates to a method and transdermal pharmaceutical composition for preventing magnesium deficiency or imbalances associated with magnesium deficiency including diabetes, hypertension, high cholesterol, cardiac arrhythmias, acute myocardial infarction, arteriosclerosis, atherosclerosis, preeclampsia, dysautonomia, mitral valve prolapse, asthma, constipation, irritable bowel syndrome, migraines, muscle spasms and cramping, premenstrual syndrome, osteoporosis, kidney stones, chronic fatigue syndrome, and fibromyalgia. The transdermal pharmaceutical composition includes a therapeutically effective amount of a pharmaceutically acceptable salt of magnesium and a pharmaceutically acceptable carrier. A therapeutically effective amount of a pharmaceutically acceptable salt of zinc a vitamin such as B-complex vitamin, a carotenoid, a mineral, or a combination thereof may also be included in the transdermal pharmaceutical composition. A  therapeutically effective amount of progesterone may also be included in the transdermal pharmaceutical composition. The transdermal pharmaceutical composition may be topically administered to prevent magnesium deficiency or imbalances caused by magnesium deficiency.
Patent CA-2555390-A1 (CA)
Title: Immunostimulatory viral rna oligonucleotides
Inventor: FORSBACH ALEXANDRA
IPC: C12Q1/68
Filed: 2005-02-18
Abstract: Immunostimulatory sequence-specific RNA oligonucleotides corresponding to 3' terminal sequences of single-stranded minus-sense RNA genomic RNAs are provided. Also provided are compositions and methods relating to an immunostimulatory 4-mer RNA motif provided as 5'-C/U-U-G/U-U-3'. Incorporation of this short RNA motif is sufficient to confer new and altered immunostimulatory properties in new and existing oligonucleotides, including CpG oligodeoxynucleotides. Also provided are methods for use of the immunostimulatory RNA oligonucleotides and DNA:RNA chimeric oligonucleotides of the invention to induce an immune response in vitro and in vivo, as well as to treat allergy, asthma, infection, and cancer in a subject. Single-stranded oligoribonucleotides of the invention are believed to signal through a Toll-like receptor (TLR) chosen from TLR9, TLR8, TLR7, and TLR3. The oligoribonucleotides can also be used in a method to screen for TLR  antagonists.
Patent CA-2556521-A1 (CA)
Inventor: JUNG KIL-SOO
IPC: G11B20/10
Filed: 2005-02-19
Abstract: La présente invention a trait à un support de stockage de données de sous-titres de texte comprenant une information de style, un appareil et des procédés de reproduction prévus pour la reproduction des données de sous-titres de texte comprenant une information de style enregistrée séparément sur le support de stockage. Le support de stockage comporte : des données d'images multimédia, et des données de sous-titres de texte pour l'affichage de sous-titres sur une image en fonction des données d'images multimédia, dans lequel les données de sous-titres de texte comprennent une information de dialogue indiquant le contenu de sous-titres à être affiché sur l'image, une information de style indiquant un style de sortie appliqué à une portion de l'information de dialogue. Ainsi, des sous-titres peuvent être fournis dans une pluralité de langues sans être limités au nombre d'unités de données de sous-titres. En outre, des données de sous-titres peuvent être facilement produites et éditées. De manière similaire, un style de sortie de données de sous-titres peut être modifié de diverses manières. Un style spécial peut également être appliqué afin de mettre en évidence une portion des sous-titres.
Patent CA-2558559-A1 (CA)
Inventor: VISKOV CHRISTIAN
IPC: C07H3/06
Filed: 2005-03-22
Abstract: The invention provides a process for preparing heparin products with a reduced content of glycoserine. A method for detecting glycoserine in preparations of heparin is also provided.
Patent CA-2558923-A1 (CA)
Inventor: FILOCHE-ROMME BRUNO
IPC: C07D471/04
Filed: 2005-03-30
Abstract: L'invention concerne les nouveaux produits de formule (I) : dans laquelle R  représente hydrogène ou est choisi parmi R2 et R3, R1 représente alkényle ou alkyle éventuellement substitué par -CO-NR7R8, -NR7R8, carboxy, hydroxyle, alcoxy ou halogène, R2 et R3 identiques ou différents représentent alkyle ou -O-alkyle éventuellement substitués par -CO-NR7R8, -NR7R8, alcoxy, alcoxy-NR7R8, carboxy ou phényle, R4, R5 et R6 identiques ou différents représentent hydrogène, halogène, cyano, amino, alcoxy ou alkyle, R4 représentant de plus -CH=O, -CH=N-OH et -CH2NHOH; R7 et R8 représentent notamment hydrogène, alkyle, alkényle, cycloalkyle, cycloalkényle, hétérocycloalkyle, aryle et hétéroaryle ou bien R7 et R8 forment avec l'atome d'azote un hétérocycle éventuellement substitué, ces produits étant sous toutes les formes isomères et les sels, à  titre de médicaments.
Patent CA-2560774-A1 (CA)
Title: Water hammer
Inventor: IN SUK SHIN
IPC: E21B4/14
Filed: 2005-03-24
Abstract: A water hammer using a drive rod is provided. The water hammer includes a tubular main body having a hollow portion; a socket coupled to an upper end of the main body and having a water pressure supply passage; a cylindrical piston housing connected to the main body; a piston slidably installed in the piston housing, for striking a bit of a bit unit installed at a lower portion of the main body, having a hollow portion through which water is discharged, an annular pressurizing portion protruding on its outer circumferential surface, and a first communication hole connected to the hollow portion; a sliding member fitted into the main body to be coupled to the piston housing, defining a valve installation space, and creating a space portion in which the piston is received when the piston is elevated; a valve member defining the valve installation space into first and third space portions along the length of the piston, the first and second space portions having different cross-sectional areas from each other, and valve member forming a second space portion between the first and third space portions, connected to the hollow portion of the piston and connected to the first space portion when the piston is elevated;  and a water pressure supply unit for supplying high pressure water delivered to the water pressure supply passage of the socket to the first and second space portions.
Patent CA-2561001-A1 (CA)
Inventor: SEHITOGLU HASAN
IPC: G06F17/14
Filed: 2005-06-06
Abstract: The present invention relates to a novel matrix-valued transform framework to process digital signals. According to one aspect of the invention, matrix-valued methods and apparatus are described to transform a vector-valued discrete-time data sequence from time-domain into frequency-domain. In another aspect, matrix-valued methods and apparatus are described to transform a vector-valued data sequence from frequency-domain into time-domain.  Furthermore, the new framework disclosed in this invention also provides a plurality of methods and apparatus for basic signal processing functions and operations of a matrix-valued communication system. These functions and operations include but are not limited to matrix-valued fast Fourier transformation, matrix-valued linear and circular convolution, matrix-valued correlation, matrix-valued multiplexing and de-multiplexing, and matrix-valued data coding and decoding.
Patent CA-2561615-A1 (CA)
Inventor: SOGABE TOMOHIRO
IPC: H01L41/187
Filed: 2006-09-29
Abstract: For the purpose of preventing the degradation of the piezoelectric strain properties when Cu is used for internal electrodes, there is provided a piezoelectric ceramic composition including: a composite oxide, as a main constituent thereof, represented by (Pb a-b Me b) [ (Zn1/3Nb2/3)x Ti y Zr z]O3 with the proviso that 0.96 <= a <= 1.03, 0 5 b <= 0.1, 0.05 <= x <= 0.15, 0.25 <= y <= 0.5, 0.35 <= z <= 0.6, and x + y + z = 1, and Me represents at least one selected from Sr, Ca and Ba; and at least one selected from Co, Mg, Ni, Cr and Ga as a first additive to the main constituent in a content of 0.5% by mass or less (not inclusive of 0) in terms of oxide, wherein an electrode made of Cu is to be disposed on the piezoelectric ceramic composition.
Patent CA-2562821-A1 (CA)
Title: Composition and method for raising blood glucose level
Inventor: GLUSKIN ANNA E
IPC: A61M11/00
Filed: 2006-10-06
Abstract: Composition and method of administering the composition to oral mucosa, to raise the blood glucose (sugar) level of an individual. The composition comprises:   a. an effective amount of glucose, b. an effective amount of at least one absorption enhancer chosen from lecithin, hyaluronic acid, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linoleic acid, linolenic acid, monoolein, monooleates, monolaurates, borage oil, evening primrose oil, menthol, trihydroxy oxo cholanyl glycine, glycerin, polyglycerin, lysine, polylysine, triolein, polyoxyethylene ethers, polidocanol alkyl ethers, chenodeoxycholate, deoxycholate, alkali metal salicylate, pharmaceutically acceptable edetate, and pharmaceutically acceptable salts and analogues thereof, and c. an effective amount of a pharmaceutically acceptable carrier, wherein the composition is free of any active pharmaceutical agents. Also disclosed are non-aerosol dispensers containing and for use in administering the composition, and the use of the composition to raise blood glucose levels, to treat hypoglycemia or low blood sugar, or in the manufacture of a product to treat hypoglycemia or low blood sugar.
Patent CA-2562846-A1 (CA)
Title: Sulphur-linked imidazole compounds for the treament of hiv
Inventor: JONES LYN HOWARD
IPC: C07D233/84
Filed: 2005-04-11
Abstract: This invention relates to isophthalonitrile derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R3 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives.The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
Patent CA-2563177-A1 (CA)
Title: Jacking frame having a wellhead centralizer
Inventor: POLSKY YAROM
IPC: E21B19/22
Filed: 2006-10-10
Abstract: A jacking frame for an oil well offshore platform is provided that includes a support structure; a coiled tubing injector supported by the support structure and having a longitudinal axis; and a centralizer attached to the support structure, which moves a wellhead of the platform into alignment with the longitudinal axis of the coiled tubing injector.
Patent CA-2565866-A1 (CA)
Inventor: FROST RICHARD R
IPC: B65D33/00
Filed: 2006-10-27
Abstract: A bag is provided for enclosing a newspaper or other periodical. The bag includes a bottom sealed end and a top enclosing end. The elongated bag preferably includes a first panel and a second panel secured to one another along their bottom and respective side edges. A third panel adjoins the top edge of the first panel and extends downwardly toward the bottom edge of the first panel. The right edge of the third panel is secured to the right edge of the first panel and the left edge of the third panel is secured to the left edge of the first panel. The first panel and the third panel cooperatively define a pocket oriented downwardly. The second panel includes a flap section which extends upwardly beyond the top edge of the first panel and the adjoining top edge of the third panel. The flap section of the second panel is folded over the periodical and inserted between the periodical and the first panel. The third panel is flexed over the flap section to extend downwardly over the second panel.
Patent CA-2566974-A1 (CA)
Title: Treatment with oxaliplatin and an egfr-inhibitor
Inventor: KOLINSKY KENNETH
IPC: A61K33/243
Filed: 2005-05-25
Abstract: The present invention provides a method for manufacturing a medicament intended for treating tumors or tumor metastases, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and oxaliplatin is used, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and oxaliplatin combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practising this invention is the compound erlotinib HCl (also known as TarcevaTM).
Patent CA-2569355-A1 (CA)
Inventor: VAETH J STUART
IPC: H04L9/32
Filed: 2006-11-29
Abstract: The invention consists of a method of handling permits, comprising the steps of: (a) providing a user with a user permit linked to a user authentication token, the user permit defining permissions granted to the user and the user token containing identity authentication information for the user; (b) presenting the user token to a gatekeeper to confirm the user's identity; (c) validating the user permit based on the permit issuer's digital signature and (d) granting the user access based on said permissions within the user permit.
Patent CA-2570433-A1 (CA)
Title: Medicaments for inhalation comprising pde iv inhibitors and enantiomerically pure glycopyrrolate salts
Inventor: PIEPER MICHAEL P
IPC: A61P11/00
Filed: 2005-06-13
Abstract: The present invention relates to novel pharmaceutical compositions based on PDE IV inhibitors (2) and salts of formula (1) wherein X may have the meanings defined in the description and claims, and their use in the treatment of respiratory complaints.
Patent CA-2570855-A1 (CA)
Title: Online menu and food preparation systems and methods
Inventor: GANGJI ARIF
IPC: G06Q50/12
Filed: 2006-12-08
Abstract: Online menu and food preparation systems and methods are disclosed. In an exemplary embodiment, a method may comprise assisting an owner of a kitchen business to at least partially customize the plurality of customer screens. The method may also comprise using the customer screens to assist a customer of the kitchen business to build a meal online.  The method may also comprise using the customer screens to schedule a session for the customer to come prepare the meal at a physical location of the kitchen business.
Patent CA-2571454-A1 (CA)
Title: Analytical method and instrument
Inventor: KNOBEL ROLF
IPC: G06F17/17
Filed: 2006-12-18
Abstract: Subjects of the invention are a method for determination of an analyte using a particular algorithm based on a mathematical model for transforming measurement data into a growth curve and an analytical instrument comprising a computing unit for more precise determination of an analyte.
Patent CA-2572202-A1 (CA)
Title: Expanding multiple tubular portions
Inventor: MCHARDY COLIN
IPC: E21B29/00
Filed: 2006-12-14
Abstract: Apparatus for expanding first and second portions of a downhole tubular in a single trip comprises a support and first and second expansion devices. The first expansion device is mounted on the support and is operable to expand a first portion of tubular. The second expansion device is mounted to a second portion of tubular and is adapted to be engaged by the support following the expansion of the first portion of tubular, and is then used to expand the second portion of tubular.
Patent CA-2574308-A1 (CA)
Title: Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
Inventor: ELWORTHY TODD RICHARD
IPC: A61P31/18
Filed: 2005-07-20
Abstract: The present invention relates to a compounds according to formula (I), methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula (I) and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula where R1, R2, R3, R4, R5, are as defined herein.
Patent CA-2575685-A1 (CA)
Inventor: CARNEY JOHN
IPC: E04F11/18
Filed: 2005-03-31
Abstract: A connector device for interconnecting two members, the device including a first body portion (5) arranged for abutment with a surface of one of the two members, a second body portion (14) moveably attached to the first body portion. The device has attachment means (7) for attachment thereof to the other of the two members, and locking means including a locking member (6) arranged to be secured, by action of said abutment with said surface, into a locking position of engagement with the second body portion such that movement of the second body portion relative to the first body portion is restrained by the engaged locking member.
Patent CA-2583669-A1 (CA)
Inventor: SMALLEY BRIAN LESLIE
IPC: B65D71/00
Filed: 2005-10-13
Abstract: A fully enclosed paperboard carton (10) having a top (12), a base (18), a pair of oppositely disposed sides and a pair of oppositely disposed end panels (27, 29). Each end panel being substantially planar and perpendicular to the base and top. Each side having a lower portion (15, 20) that is substantially planar and perpendicular to the base (18) and an upper portion (14, 22) that is substantially planar and tapers inwardly towards its edge connection with the top (12).
Patent CA-2583731-A1 (CA)
Title: Scattered light smoke detector
Inventor: KAELIN AUGUST
IPC: G08B29/24
Filed: 2005-10-06
Abstract: The invention relates to a scattered light smoke detector containing an optoelectronical assembly for measuring scatter signals (SB, SF) detected below at least one forward scatter angle and at least one backscatter angle and evaluation electronics for determining an alarm value in accordance with the difference between the scatter signals (SB, SF). Smoke signals (BW, FW) are produced from the scatter signals (SB, SF) by means of a pre-processing step (14) and a measured value (S) is obtained from the smoke signals. The measured value (S) is formed by a linear linking of the sum of the smoke signals (BW, FW) to the difference between the smoke signals (BW, FW) or by establishing the value for the difference between the smoke signals (BW, SW).  The linear linking is calculated according to the formula [k1(BW+FW) + k2(BW-FW)], in which k1 and k2 represent two constants that are influenced among others by an application factor that is dependent on the environmental conditions in the installation location of the detector.
Patent CA-2584102-A1 (CA)
Inventor: MEINDERS ERWIN R
IPC: G11B7/26
Filed: 2005-10-12
Abstract: The present invention relates to a recording stack for obtaining a high-density relief structure, comprising: a first recording layer (10) on top of a second recording layer (12), the recording layers being supported by a substrate layer (14), wherein, upon projecting light on the recording layers, a local interaction of the recording layers leads to marks (16) on the basis of a local change of the properties with respect to chemical agents of the recording layers. The present invention further relates to a method of manufacturing a relief structure and a method of producing an optical data carrier.